Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF

The benefit of β-blockers post-myocardial infarction (MI) was established in the late 1970s. Major advances in the treatment of MI have since occurred. However, patients with chronic heart failure (CHF) were excluded from those trials. The purpose of this study was to assess the effect of β-blockers...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2003-10, Vol.146 (4), p.721-728
Hauptverfasser:	Jánosi, András, Ghali, Jalal K, Herlitz, Johan, Czuriga, István, Klibaner, Michael, Wikstrand, John, Hjalmarson, Ȧke
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Aged Angioplasty Angioplasty, Balloon, Coronary Beta blockers Biological and medical sciences Cardiology. Vascular system Coronary Artery Bypass Coronary heart disease Double-Blind Method Drug therapy Female Follow-Up Studies Heart Heart attacks Heart failure Heart Failure - complications Heart Failure - drug therapy Heart Failure - mortality Hospitalization Humans Male Medical sciences Metoprolol - analogs & derivatives Metoprolol - therapeutic use Middle Aged Mortality Myocardial Infarction - complications Myocardial Infarction - drug therapy Myocardial Infarction - mortality Stroke Volume - drug effects Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!